Luteolin as an adjuvant effectively enhanced the efficacy of adoptive tumor-specific CTLs therapy.
Saved in:
| Title: | Luteolin as an adjuvant effectively enhanced the efficacy of adoptive tumor-specific CTLs therapy. |
|---|---|
| Authors: | Lai, Zhiheng1,2 (AUTHOR), Pang, Yanyang1 (AUTHOR), Zhou, Yujing3 (AUTHOR), Chen, Leiyuan1 (AUTHOR), Zheng, Kai4,5 (AUTHOR), Yuan, Shiguo4,5 (AUTHOR) ysg@smu.edu.cn, Wang, Wu1 (AUTHOR) lxd8860@163.com |
| Source: | BMC Cancer. 3/6/2025, Vol. 25 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-025-13831-8 |